Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2013
11/19/2013US8586340 Selective posttranslational modification of phage-displayed polypeptides
11/19/2013US8586338 Ligand functionalized substrates
11/19/2013US8586293 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
11/19/2013CA2707235C Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
11/19/2013CA2695939C Modified bacteriophage
11/19/2013CA2592366C Recombinant foot and mouth disease vaccine
11/19/2013CA2434845C Hepatitis c virus replicons and replicon enhanced cells
11/19/2013CA2353866C Treatment of papillomavirus infections
11/19/2013CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
11/14/2013WO2013169961A1 Conformationally specific viral immunogens
11/14/2013WO2013169102A1 A bacteriophage for biocontrol of salmonella and in the manufacturing or processing of foods
11/14/2013WO2013166609A1 Rotavirus-like particle production in plants
11/14/2013WO2013087945A3 Influenza virus reassortment
11/14/2013US20130302790 Infectious hepatitis e virus genotype 3 recombinants
11/13/2013EP2662456A1 Methods and compositions for detecting BK virus
11/13/2013CN103392001A Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
11/13/2013CN103391788A Inactivated poliovaccine
11/13/2013CN103387996A Canine parvovirus-like particles and preparation method and application thereof
11/13/2013CN103387958A Human embryonic lung fibroblastic cell SV-7 and application thereof
11/13/2013CN103387957A Human embryonic lung fibroblastic cell SV-4 and application thereof
11/13/2013CN103387952A New application of gamma-secretase inhibitor and method for improving susceptibility of eukaryotic cells to coxsackie virus B (CVB)
11/13/2013CN103387615A Hand-foot-and-mouth disease vaccine based on HBc and EV71 VP4, and preparation method and application thereof
11/13/2013CN103386127A Method for preparing vaccine by Newcastle disease virus cultured by using chick embryo continuous cell line and bioreactor
11/13/2013CN103386125A Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine
11/13/2013CN102649963B Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer
11/13/2013CN102477091B Rice male sterile protein and coding gene and application thereof
11/13/2013CN102154228B Flow through purification processes for large biomolecules
11/13/2013CN102007209B Optimisation of expression of parvoviral rep and cap proteins in insect cells
11/12/2013US8580554 Method of producing a polypeptide or virus of interest in a continuous cell culture
11/12/2013US8580277 Influenza hemagglutinin and neuraminidase variants
11/12/2013US8580276 Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof
11/12/2013CA2493142C Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
11/07/2013WO2013164389A1 Avian cell line and its use in production of protein
11/07/2013WO2013163727A1 Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
11/07/2013WO2013163724A1 Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
11/07/2013US20130296541 Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
11/07/2013US20130296252 Muc18 targeting peptides
11/07/2013US20130295667 Serum-free mammalian cell culture medium, and uses thereof
11/07/2013US20130295647 Method of producing bacteriophage preparations comprising purification using affinity chromatography
11/07/2013US20130295137 Compositions And Methods For Treatment Of Microbial Infections
11/07/2013US20130295124 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof
11/07/2013US20130295053 Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
11/06/2013EP2660316A1 Avian cell line and its use in production of protein
11/06/2013EP2658967A1 Means for generating adenoviral vectors for cloning large nucleic acids
11/06/2013EP2658571A1 Inactivated poliovaccine
11/06/2013CN103382475A DNA fragment related to drought tolerance and alkali resistance of plant and application thereof
11/06/2013CN103382460A Strain of Marek's disease virus vaccine strain, and separation and identification and application thereof
11/06/2013CN102925486B Porcine circovirus type 2 subunit vaccine, and preparation method and application thereof
11/06/2013CN102776156B Gene VIb subtype Rubulavirus Newcastle disease virus attenuated strain VIbI4 and construction method thereof
11/06/2013CN102634527B Recombinant human NADH (nicotinamide-adenine dinucleotide) dehydrogenase subunit-4 gene and constructing method of expression vector thereof
11/06/2013CN102559612B Recombinant newcastle disease virus LaSota vaccine strain for expressing Nipah virus encephalitis G-protein
11/06/2013CN102131920B Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof
11/06/2013CN101864400B Specific recombinant adenoviruses, preparation thereof and use thereof
11/05/2013US8574591 Multi plasmid system for the production of influenza virus
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
10/2013
10/31/2013US20130288339 Purification of vaccinia viruses using hydrophobic interaction chromatography
10/31/2013US20130288337 Copolymer, complex and method for releasing viruses using ph-dependence of the copolymer
10/30/2013EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
10/30/2013EP2655613A1 Virus like particle production in plants
10/30/2013EP2655604A1 Adenovirus serotype 26 and serotype 35 filovirus vaccines
10/30/2013EP2655603A2 Novel bacteriophage and antibacterial composition comprising the same
10/30/2013CN103374580A Enterovirus 71 (EV 71) Fuyang strain and cDNA (deoxyribonucleic acid) infectious clone of attenuated strain of enterovirus 71 (EV 71) Fuyang strain as well as application of enterovirus 71 (EV 71) Fuyang strain
10/30/2013CN103374550A Construction and application of SHIV (simian/human immunodeficiency virus) infectious clone
10/30/2013CN103374549A Novel EV71 virus strain and application thereof
10/30/2013CN103374547A Method for preparing purified foot-and-mouth disease vaccine
10/30/2013CN103374064A Plant root hair development related protein TaRSL4, and coding gene and application thereof
10/30/2013CN103374063A Plant root hair development related protein TaRHD6, and coding gene and application thereof
10/30/2013CN102671192B Human diploid cell rabies vaccine and preparation method thereof
10/30/2013CN102614508B Virus split deactivation method for human influenza virus split vaccine
10/30/2013CN102559610B Recombined duck virus enteritis viral vaccine strain CCTCC for expressing bird flu virus hemagglutinin (HA) gene (rDEVus78Ha) as well as establishing method and application thereof
10/30/2013CN102550458B Technique for allowing aquatic invertebrate larvae and parents to harmlessly carry Vibrio phages
10/30/2013CN102399271B Protein used for controlling sizes of seeds and organs, coding gene thereof, and application thereof
10/30/2013CN102215865B Methods for purification of viruses
10/30/2013CN101883856B Influenza virus-like particles (VLPs) comprising hemagglutinin produced within plant
10/29/2013US8569472 Efficient cell culture system for hepatitis C virus genotype 6A
10/29/2013US8569471 Stem cell beacon
10/29/2013US8568972 Substances causing differentiation
10/29/2013US8568739 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
10/29/2013CA2612362C Cdna construct of salmonidae alphavirus
10/29/2013CA2548162C Serum-free vero cell banking process
10/29/2013CA2453100C Novel human hepatoma lines, methods for obtaining same and uses thereof
10/24/2013WO2013158879A1 Composition and methods for highly efficient gene transfer using aav capsid variants
10/24/2013WO2013158706A1 Method to produce virus in cultured cells supplemented with alpha-ketoglutarate
10/24/2013WO2013158265A1 Imaging methods for oncolytic virus therapy
10/24/2013WO2013157813A1 Novel bacteriophage, and antibacterial composition containing same
10/24/2013US20130280811 Plasmids and phages for homologous recombination and methods of use
10/24/2013US20130280299 Viral vectors and their use in therapeutic methods
10/23/2013EP2653536A1 Method for preparing bacteriophages modified by the insertion of random sequences in the target proteins of said bacteriophages
10/23/2013CN103370411A Adenovirus serotype 26 and serotype 35 filovirus vaccines
10/23/2013CN103370078A Novel European PRRSV strain
10/23/2013CN103370077A Commercial scale process for production of PRRSV
10/23/2013CN103364551A ELISA (enzyme-linked immuno sorbent assay) detection kit for porcine reproductive and respiratory syndrome virus IgM (immunoglobulin m) antibodies as well as preparation method and application of ELISA detection kit
10/23/2013CN103361319A MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
10/23/2013CN103361318A Kit for biological control of mikania micrantha by use of mikania micrantha wilt virus and method
10/23/2013CN102443063B Anti-TNFalpha humanized Fab, humanized antibody and its application
10/22/2013US8563706 Efficient cell culture system for hepatitis C virus genotype 1A and 1B
10/22/2013US8563285 Isoforms of eIF-5A: senescence-induced eIF5A; wounding-induced eIF-5A; growth eIF-5A; and DHS
10/22/2013CA2673395C Human endogenous retrovirus with foamy-like properties and uses thereof
10/22/2013CA2525698C A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
10/17/2013WO2013154928A1 Systems and methods of virus propagation in cell culture for vaccine manufacture
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 267